LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $607,050 | -16.9% | 10,131 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $730,445 | -2.9% | 10,131 | -0.9% | 0.00% | 0.0% |
| Q1 2023 | $752,225 | +10.1% | 10,226 | -0.0% | 0.00% | 0.0% |
| Q4 2022 | $683,431 | -22.4% | 10,231 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $881,000 | -3.7% | 10,231 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $915,000 | -33.9% | 10,261 | -16.6% | 0.00% | -20.0% |
| Q1 2022 | $1,384,000 | -40.3% | 12,303 | -18.1% | 0.01% | -28.6% |
| Q4 2021 | $2,320,000 | +11.6% | 15,021 | +0.7% | 0.01% | 0.0% |
| Q3 2021 | $2,078,000 | +8.3% | 14,917 | +2.0% | 0.01% | 0.0% |
| Q2 2021 | $1,919,000 | -56.5% | 14,630 | -49.5% | 0.01% | -58.8% |
| Q1 2021 | $4,414,000 | +37.2% | 28,955 | -10.5% | 0.02% | +41.7% |
| Q4 2020 | $3,217,000 | +38.4% | 32,344 | +32.7% | 0.01% | +20.0% |
| Q3 2020 | $2,324,000 | -3.3% | 24,377 | +13.5% | 0.01% | -9.1% |
| Q2 2020 | $2,403,000 | +47.0% | 21,482 | -4.4% | 0.01% | +10.0% |
| Q1 2020 | $1,635,000 | -45.6% | 22,480 | -22.0% | 0.01% | -33.3% |
| Q4 2019 | $3,006,000 | +5.7% | 28,825 | +0.9% | 0.02% | -6.2% |
| Q3 2019 | $2,843,000 | -68.8% | 28,559 | -64.2% | 0.02% | -69.2% |
| Q2 2019 | $9,117,000 | -19.9% | 79,868 | -11.8% | 0.05% | -24.6% |
| Q1 2019 | $11,382,000 | -42.4% | 90,538 | -37.9% | 0.07% | -52.1% |
| Q4 2018 | $19,771,000 | -46.6% | 145,693 | +8.0% | 0.14% | -36.6% |
| Q3 2018 | $37,027,000 | +29.5% | 134,892 | -2.3% | 0.23% | +16.4% |
| Q2 2018 | $28,601,000 | +31.0% | 138,058 | +4.4% | 0.20% | +26.6% |
| Q1 2018 | $21,837,000 | +30.3% | 132,216 | +8.0% | 0.15% | +35.1% |
| Q4 2017 | $16,761,000 | -1.0% | 122,404 | -1.5% | 0.11% | -10.2% |
| Q3 2017 | $16,923,000 | +7.6% | 124,295 | -4.1% | 0.13% | +7.6% |
| Q2 2017 | $15,731,000 | +16.1% | 129,577 | +1.2% | 0.12% | +8.3% |
| Q1 2017 | $13,545,000 | +16.2% | 127,983 | +11.6% | 0.11% | +4.8% |
| Q4 2016 | $11,652,000 | +33.6% | 114,669 | +34.2% | 0.10% | +35.1% |
| Q3 2016 | $8,722,000 | +7.5% | 85,458 | +25.6% | 0.08% | +1.3% |
| Q2 2016 | $8,113,000 | +17.2% | 68,023 | +5.2% | 0.08% | +16.9% |
| Q1 2016 | $6,922,000 | +3.8% | 64,646 | +5.1% | 0.06% | +3.2% |
| Q4 2015 | $6,666,000 | -42.8% | 61,494 | -54.8% | 0.06% | -37.6% |
| Q3 2015 | $11,646,000 | -92.2% | 135,975 | -90.8% | 0.10% | -54.5% |
| Q2 2015 | $148,489,000 | +31.9% | 1,471,643 | +0.8% | 0.22% | +28.3% |
| Q1 2015 | $112,578,000 | +81.6% | 1,459,973 | +25.3% | 0.17% | +73.0% |
| Q4 2014 | $61,991,000 | +25.0% | 1,165,039 | +10.4% | 0.10% | +17.6% |
| Q3 2014 | $49,589,000 | -5.6% | 1,055,321 | +25.1% | 0.08% | -1.2% |
| Q2 2014 | $52,554,000 | -16.6% | 843,711 | -9.9% | 0.09% | -17.3% |
| Q1 2014 | $63,010,000 | +0.2% | 936,671 | -21.7% | 0.10% | 0.0% |
| Q4 2013 | $62,908,000 | +572.7% | 1,195,983 | +453.5% | 0.10% | +511.8% |
| Q3 2013 | $9,351,000 | – | 216,068 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |